Viveve Medical, Inc.
Viveve Medical, Inc. (VIVE) Revenue
Annual & quarterly revenue history · segment & region breakdown
VIVE · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsViveve Medical, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 17.28% year-over-year from $0.01B in FY2021.
Revenue trend
2021 – 2002 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-12-31 | $0.01B | +$0.00B | +17.28% |
| 2020-12-31 | $0.01B | -$0.00B | -16.57% |
| 2019-12-31 | $0.01B | -$0.01B | -64.54% |
| 2018-12-31 | $0.02B | +$0.00B | +21.12% |
| 2017-12-31 | $0.02B | +$0.01B | +114.09% |
| 2016-12-31 | $0.01B | +$0.01B | +393.50% |
| 2015-12-31 | $0.00B | +$0.00B | +1507.78% |
| 2014-12-31 | $0.00B | -$0.00B | -92.94% |
| 2013-12-31 | $0.00B | +$0.00B | +17.96% |
| 2012-12-31 | $0.00B | +$0.00B | +60.95% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Viveve Medical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Viveve Medical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Viveve Medical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
VIVE revenue · 4 questionsVIVE's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 17.28% year-over-year from $0.01B in FY2021.
▸ Source: FMP · Viveve Medical, Inc. SEC filings · GAAP · Viveve Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026